Valuation Roche Holding AG London S.E.

Stocks

Market Closed - London S.E. Other stock markets 08:50:00 31/07/2026 pm IST			5-day change	1st Jan Change
323.90 ^CHF	-.--%		-.--%	-1.29%

28/07	Sika raises annual sales-growth outlook after strong first-half performance	RE
27/07	IDEAYA Biosciences Advances IDE892 Into Phase 1/2 Monotherapy Expansion	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	3,06,810	2,39,812	1,97,073	2,05,191	2,62,098	2,82,270	-	-
Change	-	-21.84%	-17.82%	4.12%	27.73%	7.7%	-	-
Enterprise Value (EV) ¹	3,24,977	2,55,396	2,15,772	2,22,528	2,78,258	2,93,015	2,86,233	2,78,296
Change	-	-21.41%	-15.51%	3.13%	25.04%	5.3%	-2.31%	-2.77%
P/E	23.4x	18.9x	17.1x	24.8x	20.5x	19.7x	17.5x	16.1x
PBR	13.2x	8.29x	5.91x	5.67x	7.8x	7.05x	5.92x	5.01x
PEG	-	-3.69x	-2.48x	-0.9x	0.4x	1.7x	1.4x	1.93x
Capitalization / Revenue	4.89x	3.79x	3.36x	3.39x	4.26x	4.51x	4.31x	4.11x
EV / Revenue	5.17x	4.04x	3.67x	3.68x	4.52x	4.68x	4.37x	4.05x
EV / EBITDA	13.2x	10.2x	9.82x	9.45x	11.3x	11.6x	10.5x	9.62x
EV / EBIT	14.8x	11.5x	11.2x	10.7x	12.7x	12.9x	11.8x	10.8x
EV / FCF	20.7x	19.6x	19.1x	14.5x	23.6x	19.1x	17.5x	15.8x
FCF Yield	4.83%	5.11%	5.23%	6.89%	4.24%	5.23%	5.7%	6.35%
Dividend per Share ²	9.3	9.5	9.6	9.7	9.8	9.992	10.22	10.49
Rate of return	2.45%	3.27%	3.93%	3.8%	2.99%	2.83%	2.89%	2.97%
EPS ²	16.2	15.37	14.31	10.31	16.04	17.95	20.23	21.92
Distribution rate	57.4%	61.8%	67.1%	94.1%	61.1%	55.7%	50.5%	47.9%
Net sales ¹	62,801	63,281	58,716	60,495	61,516	62,645	65,471	68,719
EBITDA ¹	24,692	25,015	21,976	23,538	24,608	25,278	27,191	28,937
EBIT ¹	21,897	22,173	19,240	20,823	21,833	22,630	24,189	25,738
Net income ¹	13,930	12,421	11,498	8,277	12,880	14,506	16,332	17,553
Net Debt ¹	18,167	15,584	18,699	17,337	16,160	10,745	3,963	-3,973
Reference price ²	379.10	290.50	244.50	255.50	328.20	353.60	353.60	353.60
Nbr of stocks (in thousands)	8,00,952	8,00,579	7,98,652	7,96,789	7,96,317	7,96,766	-	-
Announcement Date	03/02/22	02/02/23	01/02/24	30/01/25	29/01/26	-	-	-

¹CHF in Million²CHF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.03x	12.19x	25.61x	0.59%	1,02400Cr
JOHNSON & JOHNSON	27.48x	6.29x	17.54x	2.1%	62TCr
ABBVIE INC.	32.57x	7.42x	15.35x	2.76%	44TCr
ASTRAZENECA PLC	21.76x	4.48x	12.7x	1.96%	26TCr
NOVO NORDISK A/S	13.48x	5.05x	10.4x	3.71%	21TCr
AMGEN INC.	25.29x	6.61x	11.66x	2.62%	21TCr
GILEAD SCIENCES, INC.	-46.92x	5.63x	31.08x	2.53%	16TCr
PFIZER INC.	12.69x	3.11x	7.86x	6.88%	14TCr
BRISTOL-MYERS SQUIBB COMPANY	11.77x	3.27x	8.54x	3.87%	13TCr
Average	14.79x	6.01x	15.64x	3%	35.59TCr
Weighted average by Cap.	24.01x	7.82x	18.45x	2.14%